• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Fresh off ASCO myeloma data, Legend Bio gets $424M in biotech's biggest IPO of 2020

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 05, 2020 at 11:12: AM
via Legend Biotech, a Nanjing, China-based developer of cell therapies for cancer, is raising just over $420 million in an initial public offering, announcing Friday the pricing of 18.4 million shares at $23 apiece.

article source
 

<



Similar threads

cafead
Fresh off first regulatory win, ImmunityBio hints at financial troubles
Replies
0
Views
46
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Erasca lays off 18% while swapping out KRAS program for fresh anti-tumor options
Replies
0
Views
83
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Fresh off $4B deal, Nimbus gears up for ‘third chapter’ with new fundraise
Replies
0
Views
91
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Fresh off its IPO, Sagimet adds two former Cognoa execs to corner office
Replies
0
Views
84
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
US Senate kicks off fresh round of drug pricing control legislation
Replies
0
Views
115
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote